Parameter | Cerebrospinal (CSF) Findings | HSV N = 7 | EV N = 100a | P-Valueb |
---|---|---|---|---|
CSF white blood cell count | CSF white blood cell (WBC) (× 106/L) at diagnosis, median (IQR) | 26 (2–146) | 153 (17.5–422) | 0.08 |
CSF WBC, n (%) | ||||
> 9 × 106/L | 4 (57) | 79 (79) | 0.18 | |
> 15 × 106/L | 4 (57) | 76 (76) | 0.37 | |
> 100 × 106/L | 3 (43) | 57 (57) | 0.70 | |
> 500 × 106/L | 0 | 22 (22) | 0.34 | |
> 1000 × 106/Lc | 0 | 10 (10) | 1.00 | |
> 2000 × 106/Ld | 0 | 6 (6) | 1.00 | |
Median percentage polymorphonuclear contribution to CSF cell count | 6 (3–14) | 25 (6–51) | 0.04 | |
CSF pleocytosise | 4 (57) | 77 (77) | 0.36 | |
CSF cell count with polymorphonuclear dominance (> 50%), n (%) | 0/7 (0) | 23/86 (27) | 0.19 | |
CSF red blood cell count | CSF red blood cell count (×106/L), median (IQR) | 26 (1–6950) | 23 (2–138) | 0.66 |
CSF glucose | CSF glucose (mmol/L), median (IQR) | 2.4 (2.1–2.8) | 2.4 (2.2–2.7) | 0.90 |
CSF glucose < 2.1 mmol/Lc, n (%) | 0/7 (0) | 10 (10) | 0.91 | |
CSF protein | CSF protein (g/L), median (IQR) | 0.76 (0.53–0.90) | 0.79 (0.59–1.02) | 0.86 |
Protein > 1 g/Lc, n (%) | 1 (14) | 25/98 (25) | 0.68 |